Abacavir CAS 136470-78-5 Assay 99.0%~101.0% API Factory anti-HIV

Short Description:

Chemical Name: Abacavir

CAS: 136470-78-5

Appearance: White to Off-White Crystalline Powder

Assay: 99.0%~101.0%

A powerful nucleoside reverse transcriptase inhibitor (NRTI) used to treat HIV and AIDS

API High Quality, Commercial Production

Inquiry: alvin@ruifuchem.com

Send email to us

Product Detail

Product Tags

Description:

Manufacturer Supply with High Purity and Stable Quality
Chemical Name: Abacavir
CAS: 136470-78-5
A powerful nucleoside analog reverse transcriptase inhibitor (NRTI) used to treat HIV and AIDS.
API High Quality, Commercial Production

Chemical Properties:

Chemical Name	Abacavir
CAS Number	136470-78-5
CAT Number	RF-API62
Stock Status	In Stock, Production Scale Up to Hundreds of Kilograms
Molecular Formula	C14H18N6O
Molecular Weight	286.33
Melting Point	165℃
Shipping Condition	Under Ambient Temperature
Brand	Ruifu Chemical

Specifications:

Item	Specifications
Appearance	White to Off-White Crystalline Powder
Identification	(1) IR (2) HPLC (3) Sulfate
Water	≤0.50%
Residue on Ingnition	≤0.20%
Limit of the Abacavir Enantiomer	≤0.20%
1) Related Substances
Descyclopropyl Abacavir	≤0.20%
Trans-Abacavir	≤0.20%
O-Pyrimidinyl Abacavir	≤0.20%
t-Butyl Derivate Abacavir	≤0.20%
Any Unspecific Impurity	≤0.10%
Total Impurities	≤0.80%
2) Enantiomeric Purity	Abacavir Enantiomer ≤0.20%
3) Residual Solvents
Methanol	≤0.30%
Acetone	≤0.50%
Ethanol	≤0.50%
Heavy Metals	≤20ppm
Assay	99.0%~101.0% (calculated on anhydrous and solvent free basis)
Test Standard	United States Pharmacopeia (USP) Standard
Usage	API; anti-HIV

Package & Storage:

Package: Bottle, Aluminum foil bag, Cardboard drum, 25kg/Drum, or according to customer's requirement.

Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.

Advantages:

FAQ:

Application:

Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of Abacavir (CAS: 136470-78-5) with high quality. Abacavir API is a carbocyclic 2'-deoxyguanosine nucleoside reverse transcriptase inhibitor (NRTI) and an anti-HIV drug used to treat HIV infection. NRTIs work by blocking HIV reverse transcriptase, an HIV enzyme. This product is intended for the treatment of adults infected with human immunodeficiency virus (HIV). Three fixed components (Abacavir, Lamivudine, and Zidovudine) are used in lieu of three monotherapies at similar doses. Abacavir, Lamivudine, and Zidovudine alone are recommended for 6-8 weeks at the beginning of treatment.